Home > Cancer and Treatments >
Skin Cancer Program Homepage
The Cutaneous Oncology Program consists of clinical and research programs devoted to melanoma and non-melanoma skin
cancer.
The Melanoma Multidisciplinary Clinic, designated as the National Cancer Institute's Midwest referral center,
offers patients efficient and expedited care regardless of their disease stage. Comprehensive patient care is
achieved through the concerted efforts of caretakers from 15 departments or sections, making this one of the most
active melanoma clinics in the nation. The Clinic also offers novel melanoma treatment protocols, including gene
therapy, adoptive immunotherapy, and combination chemotherapy and immunotherapy. The University of Michigan is a
leader in the field of Mohs surgery for the treatment of higher risk basal cell and squamous cell carcinoma, and
soft tissue reconstruction of skin cancer defects.
The scientific mission of the Cutaneous Oncology Program is to utilize knowledge gained from basic, preclinical
and clinical research endeavors to improve the overall care of patients with skin cancer. We believe that
understanding the molecular basis and biology of melanoma and non-melanoma skin cancers will drive future
innovations in prevention, diagnosis and treatment. Basic research efforts are focused on areas that have
relevance to all forms of cutaneous neoplasia, including the investigation of molecular, biochemical, cellular,
and tissue alterations driving the development and progression of skin cancer.
